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Abstract
Background: Effective, scalable strategies to improve maternal, fetal, and newborn health and reduce
preventable morbidity and mortality are urgently needed in low- and middle-income countries. Building on
the successes of previous checklist-based programs, the World Health Organization (WHO) and partners led
the development of the Safe Childbirth Checklist (SCC), a 28-item list of evidence-based practices linked with
improved maternal and newborn outcomes. Pilot-testing of the Checklist in Southern India demonstrated
dramatic improvements in adherence by health workers to essential childbirth-related practices (EBPs). The
BetterBirth Trial seeks to measure the effectiveness of SCC impact on EBPs, deaths, and complications at a
larger scale.
Methods/design: This matched-pair, cluster-randomized controlled, adaptive trial will be conducted in 120
facilities across 24 districts in Uttar Pradesh, India. Study sites, identified according to predefined eligibility
criteria, were matched by measured covariates before randomization. The intervention, the SCC embedded in
a quality improvement program, consists of leadership engagement, a 2-day educational launch of the SCC,
and support through placement of a trained peer “coach” to provide supportive supervision and real-time
data feedback over an 8-month period with decreasing intensity. A facility-based childbirth quality coordinator
is trained and supported to drive sustained behavior change after the BetterBirth team leaves the facility.
Study participants are birth attendants and women and their newborns who present to the study facilities for
childbirth at 60 intervention and 60 control sites. The primary outcome is a composite measure including
maternal death, maternal severe morbidity, stillbirth, and newborn death, occurring within 7 days after birth.
The sample size (n = 171,964) was calculated to detect a 15% reduction in the primary outcome. Adherence
by health workers to EBPs will be measured in a subset of births (n = 6000).
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The trial will be conducted in close collaboration with key partners including the Governments of India and
Uttar Pradesh, the World Health Organization, an expert Scientific Advisory Committee, an experienced local
implementing organization (Population Services International, PSI), and frontline facility leaders and workers.
Discussion: If effective, the WHO Safe Childbirth Checklist program could be a powerful health facility-
strengthening intervention to improve quality of care and reduce preventable harm to women and newborns,
with millions of potential beneficiaries.
Trial registration: BetterBirth Study Protocol dated: 13 February 2014; ClinicalTrials.gov: NCT02148952;
Universal Trial Number: U1111-1131-5647.
Keywords: Cluster-randomized controlled trial, WHO Safe Childbirth Checklist, Maternal health, Newborn
health, Perinatal health, Stillbirth, Coaching, Supportive supervision, Quality improvement, India
Background
Maternal and neonatal morbidity and mortality remain
unacceptably high, despite a focus on improving the
health of pregnant women and newborns through
Millennium Development Goals 4 and 5 [1–3]. Gaps in
care during labor, delivery, and the early neonatal period
are well-recognized, yet few simple and scalable strat-
egies have proven to be effective to support health
worker adherence to clinical, essential childbirth-related
practices (EBPs). Poor quality of care is of particular
concern in low- and middle-income countries where the
majority of avoidable maternal, fetal, and newborn mor-
bidity and mortality occurs [1, 2, 4].
One current global strategy is to shift childbirth from
the home to facilities, but evidence suggests that facil-
ities in many high-risk areas may be ill-prepared to
safely care for the increased patient load that this would
generate. The example of India is illustrative. As part of
the National Health Mission’s (NHM) Reproductive and
Child Health Program, the Government of India (GoI)
launched in 2005 the Janani Suraksha Yojana (JSY), a
scheme to promote institutional deliveries by linking
cash incentives for patients and Accredited Social Health
Activist (ASHA) workers with delivery and post-delivery
care at the facility. Cost reimbursement is also provided
for transport to and from health facilities [5]. From 2005
to 2010, JSY has resulted in a marked increase in the
number of institutional deliveries (25% to 53.3%), but
poor quality of care has limited the potential benefits of
facility-based delivery to these women and their neo-
nates [6]. Identifying and instituting effective, scalable
interventions at health facilities is critical to improving
quality and safety of childbirth.
Checklist-based programs have been used with in-
creasing spread and effect in health care to help pro-
viders translate evidence into high-quality patient care
[7]. This approach to improve quality has been shown to
significantly improve health outcomes in intensive care
medicine and surgery, including in low-resource settings
[8, 9]. To translate this approach to reduce maternal and
newborn harm, a partnership between the World Health
Organization (WHO) and more than 100 frontline
health workers and technical experts was established to
develop a safe childbirth checklist program. The WHO
Safe Childbirth Checklist (SCC) is comprised of 29
evidence-based practices that are associated with im-
proved maternal and newborn outcomes. Over a 2-year
period, the SCC was developed through a systematic
process including evidence and guideline review, exten-
sive consultation with content experts and potential
users, and field evaluation for usability in Africa, Asia,
and the Middle East [10]. Checklist items address the
major causes of maternal and newborn mortality in
resource-limited settings. The SCC is focused on care
delivered in facilities for births at term gestation as term
delivery represents the overwhelming majority of births.
The Checklist is designed to address quality of care at
four critical periods in the birth continuum: on admis-
sion to facility, at the time of pushing (or before
cesarean delivery), soon after birth (within 1 h), and at
discharge (see Additional file 1: Figure S1).
Limited data are available on the impact of SCC-based
programs on the uptake of EBPs and no published stud-
ies have examined the impact on maternal and infant
mortality and morbidity [11, 12]. In 2010, the SCC pro-
gram was pilot-tested at a public-sector, subdistrict-level
hospital in Karnataka, India [11]. Through a pre-post
intervention design, the program’s impact on health
workers’ adherence to EBPs was assessed. The SCC pro-
gram resulted in dramatic improvements in adherence
(increase from mean of 10/29 (34%) to 25/29 EBPs
(86%), p < 0.001). While the pilot study demonstrated
that the SCC program improved health worker perform-
ance, the study was not powered to detect a change in
maternal and perinatal health outcomes. In Sri Lanka,
the results of SCC program implementation at a
tertiary-level hospital were assessed through surveys of
birth attendants, who reported an average of 21 out of
29 EBPs conducted around the time of each delivery
[12]. While adherence to the Checklist is important,
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understanding the impact on maternal/neonatal harm is
essential for providing evidence to support broad-scale
expansion of the SCC-based programs.
The BetterBirth Trial will measure the impact that the
BetterBirth approach (checklist + coaching + data feed-
back) has on deaths and complications in institutional
childbirths through an adaptive, matched-pair, cluster-
randomized controlled study. The study will take place
in the state of Uttar Pradesh (UP), India, a largely rural
state with among the highest rates of maternal and new-
born mortality in India and globally. It is anticipated that
results from the BetterBirth Trial will be used to inform
policy-making and program development to improve
quality of care and clinical safety using the SCC for




Using a matched-pair, cluster-randomized controlled de-
sign, the intervention will be delivered at the facility (i.e.,
cluster) level with the primary outcome measured at the
individual level (i.e., mother, fetus, or newborn). The
SCC program will be introduced at 60 facilities (inter-
vention arm); the other 60 facilities will receive standard
of care services (control arm; 120 sites total). Facilities
will be enrolled as a matched pair (one intervention and
one control site) at the same time. All 60 pairs will be
initiated in a staggered fashion over a 15-month period.
In each matched pair, data collection for primary out-
comes will initiate 7 − 10 weeks after coaching begins in
the intervention and continue for up to 12 months.
Study sites will be identified from across UP, selected
according to predefined eligibility criteria. Criteria include
accessibility to investigators; a government-accredited
health center at the primary (PHC), or community (CHC)
level; three or more birth attendants on the staff who have
training at the level of an auxiliary nurse midwife or
higher; a birth volume of at least 1000 births annually; ab-
sence of ongoing research or other interventions that
could confound trial results; and willingness of adminis-
trative and clinical leaders to participate. Only public sec-
tor health facilities will be enrolled.
Uttar Pradesh has 75 administrative districts. To
maximize representation and to facilitate administra-
tive processes, five geographic “hubs” spread across
the state will be selected based on maximizing (1)
rates of institutional births, (2) absence of concurrent
institutional childbirth quality improvement programs,
and (3) prioritization by the Government of UP. Each
hub will be comprised of four to six districts with ap-
proximately 20 enrolled facilities per hub.
Matched-pairing of study sites before randomization
will be conducted by coarsened exact matching, a
monotonic imbalance bounding matching method that
estimates causal effects by reducing imbalance in covari-
ates between treated and comparison groups [13–15].
Matching will increase statistical power and efficiency,
and robustness to experimental failures [14, 16, 17].
Facilities will be matched based on functional classifi-
cation (PHC, CHC, or CHC/first referral unit (FRU));
geographic location (i.e., distance to district hospital
(DH)); annual birth volume; and number of birth at-
tendants. Within each matched pair of clusters, one
site will be randomized to receive the intervention
and the other will be the control site. Baseline facility
data will be compared to assure that matching was
successful. If a facility that is enrolled in the trial
exits the trial after enrollment, the paired facility will
also be dropped.
Setting
Uttar Pradesh is India’s most populous state with
more than 203 million people; 29.4% live below the
poverty line and 77% live in rural areas [18, 19]. In
UP, 773 CHC facilities and 3497 PHC facilities pro-
vide services to the population [20]. National initia-
tives aimed at improving maternal and newborn
health in India, including JSY, have resulted in dra-
matic increase in rates of institutional delivery, from
17.5% in 2005 − 2006 to above 50% in 2008 [21].
However, high rates of maternal and neonatal mortal-
ity persist; the maternal mortality ratio is 258 deaths/
100,000 live births and the neonatal mortality rate is
49 deaths/1000 live births in UP [22].
Study population
Women presenting for childbirth at study facilities and
their newborns will be enrolled, excluding those who
have been referred into the facility by interfacility trans-
fer and excluding women who are being managed for
abortion. Women or newborns from enrolled sites who
are referred out to another facility (before or after
delivery) will remain in the study with their outcomes al-
located to the referring facility.
Health care workers providing services during child-
birth will also be enrolled if they consent for observation
of EBPs and participation in Checklist acceptability and
utilization surveys.
Study site enrollment
Approval and support will be obtained from district
chief medical officers, after which facilities will be
approached for participation. The program will be out-
lined to facility leadership including the head of the fa-
cility (i.e., medical officer-in-charge (MOIC) or medical
superintendent (MS)) from whom a formal commitment
to participating in the study will be obtained.
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Intervention
The SCC, a bedside tool, prompts health workers to con-
duct essential, evidence-based childbirth practices. The
SCC is included in the Government of India Maternal and
Neonatal Health Toolkit (http://nrhm.gov.in/images/pdf/
programmes/maternal-health/guidelines/MNH_Toolk-
it_23_11_2013.pdf); however, it has not been used widely.
The investigators worked with the GoI and UNICEF-India
to align the SCC with national guidelines (Additional file
1: Figure S1). The adapted checklist used in the Better-
Birth Trial has 28 items to be conducted at four junctures
(“pause points”) in clinical care: on admission, at the time
of pushing (or before cesarean delivery), soon after birth
(within 1 h), and at discharge.
The BetterBirth approach is designed to maximize the
likelihood of successful introduction of the Checklist
into clinical practice and will be based on a model for
facilitating change that consists of Engage, Launch, and
Support based on five key messages (Table 1). Within
each hub, an implementation team consisting of a senior
coach manager (physician or public health practitioner
with 8 − 10 years of experience), coach team leaders (a
physician or trained public health practitioner with at
least 4 years of experience) and nurse coaches trained in
childbirth practices, SCC use and coaching techniques
will provide support for facilities. Typically, a coach
manages two to four facilities at any given time; a coach
team leader can manage four to five facilities at one
time.
Engage
At each facility, the team leader will engage the senior
administrative and clinical leaders of the facility to dis-
cuss current childbirth-related maternal and child health
issues and the potential applicability of the SCC to the
facility.
Launch
The coach team leader and coach will provide a 2-day
orientation to the SCC and quality of care at childbirth,
using an implementation flipbook and conceptual videos
to illustrate how the Checklist could be integrated into
care and utilized correctly. Further, a gap analysis is con-
ducted with facility staff to identify issues that deter staff
from providing the best care.
Support
In each facility, a locally designated Childbirth Quality
Coordinator (CQC) will be identified within the first
2 months and trained to help lead implementation and
improvement efforts at that site. Following the launch,
the team leader will continue to visit each facility regularly
(initially weekly, then fortnightly, and finally monthly) to
provide support to the CQC and administrative leaders in-
cluding addressing system barriers to effective SCC use
such as birth supplies and staff turnover. Over an 8-
month period, the coach will visit each facility twice-
weekly for the first 4 months, then weekly for 2 months,
then every 2 weeks for a month, with one final visit in the
8th month. Coaches will observe the birth attendant, rec-
ord the birth practices, and identify barriers that prevent
implementation of best practices. Coaches diagnose be-
havioral barriers along with the birth attendants. Observa-
tions will be entered into a mobile application (app) and
heat-maps of behavior over time will be automatically
generated. At each visit, the coach will review progress, in-
cluding review of completed SCCs since the prior coach-
ing visit and heat-maps, and tailor the coaching to address
gaps in clinical practices, overcome the identified barriers,
or issues related to supplies, and will coach the birth at-
tendants in effective checklist use. Checklist utilization
will be monitored and followed up over time by the team
leader, coach, and the facility-based CQC to ensure bar-
riers to Checklist use, including supplies, are identified
and addressed with the caregiver and district and facility
leadership, if necessary. No clinical skill training and no
additional commodities are supplied by the intervention
team to the facility.
There will be no intervention initially in the compari-
son arm clusters apart from the introduction of a stan-
dardized birth register for data collection (see below). At
the conclusion of the trial, components of the interven-
tion will be rolled out to all facilities if the program is
effective.
Outcomes
The primary outcome is a summary composite meas-
ure of maternal death, maternal severe morbidity,
intrapartum-related stillbirth, or newborn death oc-
curring within 7 days after birth (see Table 1). A compos-
ite metric was selected because the SCC program is
intended to reduce harm for both women and newborns,
and is also meant to influence intrapartum management
thereby reducing fetal harm. The primary outcome will be
measured by examining each of the component outcomes
Table 1 Five key messages of the SCC program
1. You can prevent complications: Most conditions leading to maternal
and newborn deaths can be avoided by simple actions. The
BetterBirth Checklist Program will help you overcome the challenges
of providing consistently safe care during childbirth.
2. Pause for 4 Pause Points during childbirth care: There are 4 Pause
Points during childbirth when it is important for you to be sure that
the woman and baby are safe.
3. Perform Essential Actions at each Pause Points: At each Pause Point,
you must complete a set of Essential Actions.
4. Prepare for routine care and possible crisis situations: Preparing for
each Essential Action will help prevent crisis situations. Preparation
occurs in advance.
5. Empower women and their companions: Women and their
companions can help you to keep the woman and baby safe.
Semrau et al. Trials  (2016) 17:576 Page 4 of 10
separately and subsequently using a test with three de-
grees of freedom to assess the causal effects of the three
outcomes on the composite measure. Outcomes occurring
during delivery or within 7 days postpartum will be cap-
tured as the SCC program is anticipated to have beneficial
effects that extend into the early postpartum period. In
addition, most women and newborns in the trial setting
leave the facility soon after birth (many in under 12 h) and
hence a substantial number of very early outcomes would
be missed if the data collection was limited to in-hospital
occurrences.
Maternal severe morbidities are included in the com-
posite to provide a measure of effect on maternal health,
since the relative infrequency of maternal death is im-
practical to use as a sole indicator of maternal harm
[23]. The WHO has published clinical, laboratory-based,
and management-based criteria for defining maternal
near-missed events (sometimes called “life-threatening
conditions”) [24, 25]. In this trial, the WHO near-missed
death criteria have been modified to contain a set of five
clinical conditions that can be practically captured by
self-report. The occurrence of any one of these five con-
ditions will constitute a maternal severe morbidity.
Management-based criteria including blood transfusion,
hysterectomy and return to the health facility for a prob-
lem will not be included in the composite measure, but
will be analyzed separately.
Prespecified secondary outcomes in the trial are listed
in Table 2. Additional outcomes include the impact of
the intervention on resource availability of essential
childbirth commodities; Checklist utilization; cost-
effectiveness; rates of medication administration; patient
satisfaction with delivery experiences; family planning
decisions; and health worker attitudes relating to safety
of mothers and newborns (see Additional file 2 and Add-
itional file 3: Figure S2).
Essential childbirth-related practices
For a subset of births (approximately 6000), birth at-
tendant behaviors will be directly measured by inde-
pendent nurse observers to measure the impact of the
SCC program on delivery of individual EBPs at the first
three of the four junctures: admission, before delivery
and within 1 h after delivery (see Table 2). Observation
is not made at the time of discharge due to the variety
of times at which women are discharged. Data will be
collected in intervention and control sites (see Add-
itional file 2 and Additional file 3: Figure S2).
Data collection
Mortality and morbidity primary outcome
Building upon the existing facility-based birth registers
in UP, a standardized birth register will be implemented
at each study site from which we will extract demo-
graphic information relating to the mother and baby;
contact information for the family and the family’s com-
munity health worker; and in-facility survival outcomes
for each mother-baby dyad. Field-based study data col-
lectors will extract the required data and enter the data
into a password-protected software application using
mobile technology, which will be automatically uploaded
to a firewalled, HIPAA-compliant server.
A call center staffed by trained data collectors using
standardized scripts will determine outcomes by com-
puter-assisted telephonic interviews (CATI). This tool was
developed in consultation with a local communication
specialist to best suit the local language, terminology, and
sensitivity towards local cultural norms.
The call center staff will attempt to follow up all
mother-baby dyads between 8 to 21 days post childbirth
to determine patient- or family-reported 0–7-day mor-
bidity and mortality outcomes. Call center staff will call
the mother (or if mother is unavailable, the woman’s
husband or other immediate family member), reconfirm
consent, and, if received, conduct the interview. If con-
tact cannot be completed by telephone, the case will be
transferred to field-based data collectors for follow-up
through home visit. The field team will visit the home,
reconfirm consent and, if received, the field-based data
collector will hand a telephone to the woman/family
member to go through the CATI interview with call cen-
ter staff to gather the outcome and patient satisfaction
information, or a field worker will collect the data dir-
ectly if telephone communication cannot be established.
Follow-up data will be entered simultaneously into a
database using a web-based form integrated with a mo-
bile application.
Essential childbirth-related practices
In a subsample of birth events at 30 sites (15 pairs), ad-
herence by health workers to essential practices outlined
Table 2 Primary and secondary trial outcomes
A. Combined maternal, fetal and newborn outcome: composite rate of
maternal death by 7 days, intrapartum-related stillbirth, early neonatal
death by 7 days, and maternal severe morbidity by 7 days. [Primary
outcome]
B. Maternal outcomes: Rate of maternal death (by 7 days), rate of
maternal severe morbidity (by 7 days), rate of inter-facility transfer,
blood transfusion, hysterectomy, facility revisit, and C-section rate.
C. Newborn outcomes: Rate of intrapartum-related stillbirth, rate of early
neonatal death (by 7 days), facility revisit, and rate of inter-facility
transfer.
D. Rates of adherence by health workers to essential childbirth practices:
In a sample of total births, uptake of the following practices will be
assessed: maternal temperature obtained on admission, maternal
blood pressure obtained on admission, partograph use, appropriate
hand hygiene (use of soap and water, and wearing clean gloves) by
health workers before 1st vaginal examination, oxytocin
administration within 1 minute after birth, appropriate intervention
for the newborn if apneic at birth, newborn weight and temperature
obtained within 1 hour after birth, and initiation of breastfeeding
within 1 hour after birth.
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on the checklist will be assessed starting approximately
8 weeks after the launch of SCC use; additional assess-
ments of EBP will be done 6 and 12 months after the
launch. Trained nurse data collectors will directly ob-
serve the health workers who attend to women and new-
borns during their labor and delivery at three of the four
checklist pause points. Data were not collected at the
fourth checklist pause point due to the variety of times
at which women are discharged. Data will be recorded
on standardized data collection forms (paper-based) and
will immediately then be entered into a mobile
application.
Facility, safety attitudes, checklist utilization, and patient
satisfaction surveys
Three surveys will be implemented at study facilities to
understand facility supply availability, health workers’
attitudes about safety and quality of care, and in the
intervention sites, health workers’ use of the checklist.
In order to obtain data on availability of safe birth sup-
plies, a facility survey will be completed in all 120 facil-
ities at baseline and every 3 months thereafter. The
health worker safe attitude surveys will be completed at
baseline and every 6 months after the study starts in all
120 sites. Checklist utilization surveys will be completed
in the 60 intervention sites at baseline and at 6 and
12 months after intervention initiation.
In the morbidity/mortality outcome interviews of the
mother-infant dyads, the interview will finish with pa-
tient satisfaction questions, inquiring about satisfaction
with delivery experience, understanding of postpartum
danger signs, and provision of family planning options.
Quality control
A robust quality control and monitoring (QCM) compo-
nent has been developed to maximize the likelihood of
quality and consistency in the implementation of the
intervention package and assess data quality. The QCM
system will have two main components: progress report-
ing by the implementation teams and in-person moni-
toring visits by designated supervisors. The coach and
coach team leader will record qualitative information
and review reports with their supervisors. Team leaders
will visit sites regularly to directly observe the quality of
intervention implementation, collect data on implemen-
tation progress, and measure achievements around (1)
rate of Checklist use (compliance), (2) the proportion of
cases for which the Checklist was completed, (3) the fre-
quency of coaching visits maintained, (4) the proportion
of birth attendants who received training, and (5) skill
transfer to the CQCs.
The data quality assurance process has been developed
to focus on the accuracy, validity and consistency of re-
search data collected. Supervisors (team leaders) will
observe data collectors to assess consistency and accur-
acy of observation and data recording and proper trans-
fer of data from paper-based to electronic data
collection. Further, a call center validation process will
be focused on ensuring the validity of call center-
collected data compared to home visit-collected infor-
mation. Finally, the data entry system has built-in quality
controls to prevent incorrect data entry (e.g., postpartum
complication occurring before admission date) or pro-
vide an alert when illogical or out-of-range values are
entered.
Power analysis
The nature of the SCC program as a health facility
innovation precludes randomization at the individual pa-
tient level; thus, the study is randomized at the cluster
(i.e., public sector facility) level. Estimating intracluster
correlation coefficients (ICCs) is necessarily based on ex-
trapolations from prior studies. ICC estimates have been
derived for maternal and newborn health from the 2005
WHO Global Survey on Maternal and Perinatal Health
[26]. Considering these available data, and following dis-
cussion with experts in biostatistics, we therefore assume
the relatively conservative ICC estimate of ICC = 0.01.
Based on available birth delivery load data, we expect
the average cluster size to be 1440 births.
Data available from UP suggest that the baseline rate
of the primary (combined) outcome may be as high as
120/1000 live births. The baseline rate used in this study
will be 60/1000; this is purposively set lower than the es-
timation due to possible inaccuracies in published data
and because available data include community-based
birth events, which may have higher mortality rates.
Based on existing health indicators in UP, and the re-
sults of the SCC program pilot study that demonstrated
marked improvement in health worker performance, it
is proposed that the detection of up to a 15.3% reduction
in primary outcome with the SCC program is achievable
and meaningful in this population. The result (using an
ICC = 0.01 and a matching design effect of 0.55) is a trial
enrolling 120 facilities (60 pairs of facilities) for a max-
imum of 171,964 births (approximately 86,000 births in
each arm) with 80% power and an alpha value of 0.05.
We may have a larger sample size enrolled in order to
attain balanced pairs and similar cluster sizes as well as
stop the pairs at a similar time point. However, we will
have 80% power to detect a smaller reduction (as small
as 10%) in the primary outcome, if the matching effect is
ultimately stronger than this conservative estimate.
Sample size for essential childbirth-related practices (EBPs)
Structured observation of birth attendant performance
will be performed on a subsample of births (n = 6000)
and assess individual behavior observations at each of
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three SCC pause points (1 observation point for the first
2 pause points, 2 observation points for pause point 3).
This will be observed from 15 matched pairs of facilities
(30 facilities), or 25% of the total study facilities. For a
given EBP, we will measure the outcome at 7–10 weeks
of coaching with an ICC = 0.01 and DeffM = 1. To assess
sustainability of intervention impact, EBP observations
will be repeated at 6 months and 12 months after inter-
vention initiation. Observations will be conducted on in-
dividual birth practices (60 births per facility × 30
facilities × 4 observation points), the Rao-Scott chi-
square test statistic will have greater than 80% power
(with a 5% type I error) to detect a minimum difference
in rates between the intervention and control sites of 8.5
per 100 (8.5%).
Data Safety Monitoring Board
A Data Safety Monitoring Board (DSMB) will be estab-
lished to oversee the safety and scientific accuracy of the
study. The DSMB will contain at least three members
external to the study team with at least two members
based in India. All members will have familiarity with re-
search in low-resource settings and an understanding of
the conditions specific to UP. Membership will include a
chairperson and individuals with expertise in biostatis-
tics, obstetrics and neonatal care. The primary responsi-
bilities of the DSMB will be to ensure subject safety and
evaluate interim results for possible early stopping (see
the next paragraph below).
Data analysis and dissemination
The Rao-Scott chi-square test statistic, which adjusts for
the matched-pair, cluster randomization scheme, will be
used to compare the rates of the primary and secondary
outcomes in the comparison and intervention groups.
The trial will be monitored for possible early stopping if
a large intervention effect occurs at the time of interim
analysis, using a Haybittle-Peto approach [27]. An in-
terim Rao-Scott chi-square test will be performed and
shared with the DSMB after approximately 25% (45,000)
of the total births are enrolled. In order to stop the study
at this point in favor of the SCC program, the p value
for this Rao-Scott chi-square test must be ≤0.001. How-
ever, the stopping parameters for this study will be used
as a guideline rather than as an absolute rule. Any final
decision will also consider additional endpoints such as
differences in complications, process measures, and birth
attendant compliance to the Checklist [17]. If the study
is halted by the DSMB, the intervention will be rolled
out to all sites.
If the study continues, the final analysis will be after
enrollment and follow-up are completed. Using the
Haybittle-Peto approach, the p value for this Rao-Scott
chi-square test must be ≤0.05 for the intervention and
comparison groups to be declared significantly different.
Secondary analyses will use the Rao-Scott chi-square
test, adjusted for matching and clustering, to compare
groups with respect to selected individual health out-
comes and birth attendant EBP adherence. Since these
are secondary analyses, no formal stopping rules will be
applied and all tests will be performed at a 5% type I
error rate. The surveys for Checklist utilization, health
worker safety attitudes, and patient satisfaction will be
analyzed by comparing proportions of responses be-
tween the intervention and comparison groups.
The study investigators will have access to the final
trial dataset; however, the study biostatistician will have
access to the unblinded dataset during the interim ana-
lysis. In accordance with the funding agreement with the
Bill & Melinda Gates Foundation, the publications will
be on “open access” terms and datasets will be access-
ible. The study results will be disseminated to internal
and external collaborators, funders, scientific media, and
policymakers, including Government of Uttar Pradesh
and Government of India officials. The investigators will
take the lead in publication of the study to share results
with stakeholders and the broader scientific community.
Ethical considerations
Consent procedures
In order to obtain consent for follow-up at 7 days post-
partum of mother-infant pairs, informed verbal consent
will be obtained from the mother or her surrogate by
health workers when being discharged from study facil-
ities after delivery or at the time of referral. Documenta-
tion of verbal consent will be included in the birth
register and documented by a witness. A printed infor-
mation sheet will be provided in Hindi to the mother.
When consented mothers receive a follow-up call or
home visit, consent will be confirmed.
In the smaller sample of birth events that will be ob-
served for EBP uptake, written informed consent will be
obtained from the mother or her surrogate and verbal
consent from the health worker conducting the delivery.
If the mother or surrogate does not consent, health
worker written consent cannot be obtained, or the health
worker refuses, the birth event will not be observed.
Participation in the study for the women and health
workers will be voluntary with the ability to opt out at
any time. No monetary incentives will be provided
reflecting the limited time required. In such a case
where the mother opts out, the care provided to the
mother (and the baby) during the admission and after
discharge will not be any different from what she, and
the baby, would have received as a study participant.
To protect the privacy of study participants, every
birth event will be allotted a unique identifier code; all
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paper forms will be retained in locked cabinets at the fa-
cility and central office. All electronic data will be main-
tained on a HIPAA-compliant encrypted database.
Discussion
The Safe Childbirth Checklist is a WHO-branded tool
developed by frontline health workers and technical
experts in maternal health, newborn health, checklist-
based programs, quality improvement, and implementa-
tion science [10]. After several years in development,
including field-testing for usability and a pilot study of
its impact on health worker practices, the multicenter
trial, testing the BetterBirth approach to Checklist im-
plementation in UP will now assess the effectiveness of
the program in reducing avoidable maternal, fetal, and
newborn harm. The trial, as designed, will provide cru-
cial rigorous evidence to the global maternal, neonatal
and child health community; this information is antici-
pated to inform policies and practice towards accelerat-
ing the improvement quality and safety of facility-based
delivery care and reducing mortality and morbidity of
women and newborns. As is the case with many ran-
domized controlled trials in resource-poor settings, the
overall intensity of the intervention provided within the
trial may be more extensive than what can be brought to
scale, but it is structured to allow for the identification
of the key elements required for wider-spread success.
Challenges and opportunities
There are a number of risks to the successful completion
of this large, complex trial in UP at each level—state,
district, facility, and individual—reflecting local context,
knowledge and what is required to successfully imple-
ment a Checklist program at scale along with more uni-
versal clinical trial challenges. India is a large and
diverse country with health agencies at both the national
and state levels. Rolling out a health program in the
public sector at scale in this context requires collabor-
ation and support from national, state, and district polit-
ical leaders. To ensure alignment of the trial with
policies and priorities at these levels, we will establish
regular channels of formal and informal communication
and engagement. This includes providing updates on
progress and feedback of implementation data, partner-
ing with key figures at each level to hold joint public
meetings with national, state, and district leaders to re-
flect on progress of the program and trial, and providing
training to government officials in areas of local interest.
These partnerships have ensured that our program and
trial design have been carefully reviewed and tailored to
ensure alignment with ongoing and planned government
programs. This process has also provided key insight re-
garding the feasibility of study implementation within
the infrastructure of UP. Challenges in this area will
continue as government officials change positions,
highlighting the need to ensure sustained, effective rela-
tionships even as personnel change over the relatively
long period of data collection.
At all levels, one of the most critical challenges is
the need for local champions, as well as strategies for
sustainability of the program, particularly given the
frequent reassignment of facility staff across UP. To
address this potential barrier, we have incorporated the
training of a facility-level Childbirth Quality Coordinator
(CQC) to continue supporting the use of the SCC during
the study and once study coaches have completed the
8-month-long intervention. Further, the engagement
process includes a complete discussion of Checklist
implementation and data collection. The participation
of facility leaders in the engagement and launch pro-
cesses build local buy-in for Checklist use. Similar
processes are held at the district and state levels to
ensure that priorities align and health leaders have
ownership in the project and dedication to quality of
care. All of these processes are designed to sustain
the use of the SCC.
Partnerships among the investigators and the use of
expert local staff for implementation and management
ensure that we remain cognizant of cultural and infra-
structure determinants impacting the health care and
research environments. These allow us to deal with chal-
lenges in ensuring informed consent, with ensuring
consistent meaning of questions despite variation in dia-
lects across the state, and with operational issues related
to how women use health care facilities and recover
postpartum, as well as the role of traditional birth atten-
dants in facility based births.
As has been shown previously, simply adding a check-
list to workflow will not create uptake or sustainability
[28]. The greatest challenge is in ensuring that individual
health workers successfully adopt the SCC program into
clinical practice. Sustained behavior change in any health
care setting is challenging, especially in resource-limited
settings [29]. Early pilot studies resulted in the better
understanding of how to educate birth attendants on
how to use the SCC and be motivated to improve their
own clinical practice [30]. In our lessons learned from
the pilot studies, one key finding is the importance of
using education and peer-to-peer coaching to empower
health workers to believe in their own capacity for pro-
gress, and to realize that through their own practices
they can ensure that maternal and neonatal outcomes
may be improved. Further, with the development of the
CQCs and facility staff to take on responsibility and
utilization of the SCC, we hope to empower the CQCs
such that they will be able to collect, collate, coach, in-
terpret, and feedback data to the frontline workers and
provide information to the facility leaders.
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The main risk with the data collection stems from the
lack of a comprehensive, robust existing health manage-
ment information system in the study setting. Based on
learning from the pilot, the original plan to use stan-
dardized birth registers to collect routinely available
demographics and in-facility outcome data has required
compilation of multiple primary data sources. In base-
line data collection, we have successfully collated the
data and been able to follow up women and their new-
borns after discharge by telephone. After the pilot stud-
ies, the standard maternal severe morbidity definitions
were modified to reflect the available resources. We
reviewed a range of methodologies for self-report on
these and other time-delineated outcomes [24, 31, 32].
In addition, the use of maternal near-missed deaths as a
component of a composite indicator that combines ma-
ternal and newborn outcomes is novel. Another poten-
tial risk is contamination of the control sites in this
matched-pair, randomized controlled trial. However, this
is a limited risk as the WHO Safe Childbirth Checklist
has been part of the Government of India Maternal
Health Toolkit since 2013, yet the Checklist has not
been widely adopted.
To mitigate the above risks, we adopted methodo-
logical strategies to maximize the implementation of
successful trial conduct in this real-world setting. We
completed several pilot studies in facilities in UP,
using a quality improvement methodology, and then
measured success in both effectiveness of education
as well as rates of adoption of the care practices
comprising the SCC. Through these pilot tests in nine
facilities, we progressively modified our approach until we
were certain that we had removed all identifiable impedi-
ments to successful implementation, data collection, and
monitoring [30]. These changes included but were not
limited to a complete re-evaluation of the methods for
launch and coaching support. Data from this extensive
pilot phase will not be used in the final analyses.
In summary, simple, scalable solutions are essential,
and desperately needed, to improve maternal and neo-
natal outcomes around the time of childbirth. In part-
nership with the co-principal investigators (Ariadne
Labs, a joint center of Brigham and Women’s Hospital
and Harvard T.H. Chan School of Public Health;
Community Empowerment Lab; Jawaharlal Nehru
Medical College), Population Services International, the
World Health Organization and the Governments of
Uttar Pradesh and India, along with guidance by a
Scientific Advisory Committee comprised of technical
experts in maternal and newborn health, the BetterBirth
Trial in UP has been successfully designed and initiated
implementation. Utilization of pilot studies and iterative
learning has improved the design of the trial and inter-
vention, as well as the data collection systems, for
implementation of a high-quality, large-scale study. Stud-
ies such as this with large land coverage and sample size
require immense coordination at all levels of the health
system. If the SCC and coaching intervention are found to
reduce maternal, fetal and neonatal harm, patients and
other stakeholders stand to benefit from a proven quality
improvement strategy that could potentially help influence
outcomes in millions of births each year.
Trial status
The trial has completed planning and pilot phases and is
currently enrolling.
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